Effect of raw camel milk in type 1 diabetic patients: 1 Year randomised study

Journal of Camel Practice and Research

Volumn 12, Issue 1, 2005, Pages 27-31

  Agrawal, R P ^a   Beniwal, R ^a   Sharma, S ^a   Kochar, D K ^a   Tuteja, F C ^a   Ghorui, S K ^a,b   Sahani, M S ^a,c  

^a S P MEDICAL COLLEGE   (India)

^b MAHARANA PRATAP UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (India)

^c NATIONAL RESEARCH CENTRE ON CAMEL   (India)

Author keywords

Camel milk; Glycaemic control; Insulin; Type 1 diabetic patients

Indexed keywords

EID: 33644678128     PISSN: 09716777     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Agrawal RP, Swami SC, Beniwal R, Kochar DK, Sahani MS, Tuteja FC and Ghorui SK (2003a). Effect of camel milk on glycaemic control, lipid profile and diabetes quality of life in type - 1 diabetes: a randomised prospective controlled cross over study. Indian Journal of Animal Sciences 73 (10): 1105-1110.
2. Agrawal RP, Swami SC, Beniwal R, Kochar DK, Sahani MS, Tuteja FC and Ghorui SK (2003b). Effect of camel milk on glycaemic control risk factors and diabetes quality of life in type - 1 diabetes: a randomised prospective controlled study. Journal of Camel Practice and Research 10 (1): 45-50.
3. Beg OU, Von Bahr-Lind Strom H, Zaidi ZH and Jornvall H (1986). A camel milk protein rich in half cystine. Primary structure assessment of variations, internal repeat patterns and relationship with neurophysin and other active polypeptides. European Journal of Biochemistry 15 (1): 195-201.
4. Beg OU, Von Bahr-Lind Strom H, Zaidi ZH and Jornvall H (1989). Characteristic of camel milk protein rich in proline identifies a new beta casein fragment. Regulatory Peptides 15 (1): 5-61.
5. Breitling L (2002). Insulin and anti diabetic activity of camel milk. Journal of Camel Practice and Research 9 (1): 43-45.
6. Chaillous L, Lefevre H, Thivolet C, Boitard C, Lahlou N, Atlan-Gepner C, Bouhanick B, Mogenet A, Nicolino M, Carel JC, Lecomte P, Marechaud R, Bougneres P, Charbonnel B and Sai P (2000). Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabetes Insuline Orale group. Lancet 12; 356 (9229): 545-549.
7. Davis SN, Dobbins R, Colburn C, Tarumi C, Jacobs J, Neal D and Cherrington AD (1993). Effects of hyperinsulinemia on the subsequent hormonal response to hypoglycemia in conscious dogs. American Journal of Physiology 264: E748-E755.
8. Gwinup G, Elias AN and Domurat ES (1991). Insulin and C-peptide levels following oral administration of insulin in intestinal-enzyme protected capsules. General Pharmacology 22: 243-246.
9. Hoffman A and Ziv E (1997). Pharmacokinetic considerations of new insulin formulations and routes of administration. Clinical Pharmacokinetics 33: 285-301.
10. Holl RW, Swift PGF and Mortensen HB et al (2003). Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group. European Journal of Pediatrics 162: 22-29.
11. Mortensen HB and Hougaard P (1997). Comparison of metabolic control in a cross sectional study of 2,873 children and adolescents with IDDM from 18 countries. The Hvidore Study Group on Childhood Diabetes. Diabetes Care 20: 714-720.
12. Oskarsson PR, Lins PE, Backman L and Adamson UC (2000). Continuous intraperitoneal insulin infusion partly restores the glucagons response to hypoglycemia in type 1 diabetic patients. Diabetic Metabolism 26: 118-124.
13. Pozzilli P, Pitocco D and Visalli N et al (2000). No effect of oral insulin on residual beta-cell function in recent-onset Type 1 diabetes (the IMDIAB VII). Diabetologia 43: 1000-1004.
14. Rogers A (1989). Memories of Jahangir. Atlantic Publishers and Distributor, New Delhi. p 315.
15. Shehadeh N, Gelertner L, Blazer S, Perlman R, Solovachik L and Etzioni A (2001). Importance of insulin content in infant diet: suggestion for a new infant formula. Acta Paediatr. 90 (1): 93-95.
16. Still JG (2002) Development of oral insulin: progress and current status. Diabetic Metab Res Rev 18: S29-S37.
17. Wan CK, Giacca A, Matsuhisa M, Bahrani B, Lam L, Rodgers C and Shi ZO (2000). Increased response of glucagon and glucose production to hypoglycemia with intraperitoneal versus subcutaneous insulin treatment. Metabolism 49: 984-989.
18. Wangoh J (1993) What steps towards camel milk technology? International Journal of Animal Science 8: 9-11.